Koers Correvio Pharma Corp Toronto S.E.
Aandelen
CA14159U3010
Farmaceutische producten
Omzet 2018 | 28,67 mln. 39,16 mln. 26,2 mln. | Omzet 2019 | 32,63 mln. 44,57 mln. 29,82 mln. | Marktkapitalisatie | 27,28 mln. 37,26 mln. 24,93 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2018 | -16 mln. -21,85 mln. -14,62 mln. | Nettowinst (verlies) 2019 | -35 mln. -47,8 mln. -31,98 mln. | EV/omzet 2018 | 5,13 x |
Nettoschuld 2018 | 25,92 mln. 35,4 mln. 23,68 mln. | Nettoschuld 2019 | 33,9 mln. 46,31 mln. 30,98 mln. | EV/omzet 2019 | 1,87 x |
K/w-verhouding 2018 |
-7,1
x | K/w-verhouding 2019 |
-0,68
x | Werknemers | - |
Dividendrendement 2018 * |
-
| Dividendrendement 2019 |
-
| Vrij verhandelbaar | 86,23% |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ram Ramkumar
BRD | Director/Board Member | - | - |
Andreas Stickler
BRD | Director/Board Member | 53 | - |
Robert Ford
BRD | Director/Board Member | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,15% | 72,87 mld. | |
+34,09% | 10,31 mld. | |
+40,84% | 5,23 mld. | |
-18,53% | 4,62 mld. | |
+12,65% | 3,52 mld. | |
+27,58% | 2,31 mld. | |
-39,96% | 1,78 mld. | |
-45,87% | 1,69 mld. | |
-0,50% | 1,64 mld. |